Product news

Share this article:
Shire's Vyvanse, an attention deficit and hyperactivity disorder drug, has received approval for adults. Vyvanse is now available in three additional dosage strengths.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.